Culture of Bending Rules in India Challenges U.S. Drug Agency

A bus departs a Mylan NV factory in the Maharashtra Industrial Development Corp. (MIDC) area in Nashik, Maharshtra, India, on Saturday, Jan. 26, 2019. Mylan is the world's second-largest manufacturer of generic drugs, and though it's run from Canonsburg, Pennsylvania, its operations three hours inland from Mumbai exemplify the central role India has come to play in the global generic-drug industry. Photographer: Dhiraj Singh/Bloomberg via Getty Images
A bus departs a Mylan NV factory in the Maharashtra Industrial Development Corp. (MIDC) area in Nashik, Maharshtra, India, on Saturday, Jan. 26, 2019. Mylan is the world's second-largest manufacturer of generic drugs, and though it's run from Canonsburg, Pennsylvania, its operations three hours inland from Mumbai exemplify the central role India has come to play in the global generic-drug industry. Photographer: Dhiraj Singh/Bloomberg via Getty Images
Culture of Bending Rules in India Challenges U.S. Drug Agency
ライセンスの購入
どんな用途に素材を使えますか?
¥19,800
JPY
Getty ImagesCulture of Bending Rules in India Challenges U.S. Drug Agency, ニュース写真Culture of Bending Rules in India Challenges U.S. Drug Agency, ニュース写真Culture of Bending Rules in India Challenges U.S. Drug Agency Getty Imagesでは、高品質、高解像度のニュース写真をご利用いただけますProduct #:1091621048
¥38,500¥11,000
Getty Images
In stock

詳細

制限:
商業目的またはプロモーション目的で使用する場合は、ゲッティ イメージズのオフィスへお問い合わせください。For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
クレジット:
Bloomberg / 寄稿者
報道写真番号:
1091621048
コレクション:
Bloomberg
作成日:
2019年01月23日(水)
アップロード日:
ライセンスタイプ:
リリース情報:
リリースされていません。 詳細情報
ソース:
Bloomberg
オブジェクト名:
INDIA MYLAN
最大ファイルサイズ:
4000 x 2667 px (33.87 x 22.58 cm) - 300 dpi - 3 MB